Sarepta Therapeutics, Inc. (SRPT) stock
SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3085% below fair value
$16.01−0.67 (-4.02%)
Close on Nov 12, 2026Market cap $1.69BP/E –Yield –
Sarepta Therapeutics statistics
87 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.13
- 2.29
- P/OCF Ratio
- 9.11
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 0.50
- 2.60
- EV / FCF
- 5.50
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- 0.26%
- 10.9%
- Shares Change (QoQ)
- 1.52%
- 0.51%
- Float
- 99M
- 49M
- Shares Held by Insiders
- 5.88%
- 12.1%
- Shares Held by Institutions
- 102.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 19M
- –
- Short Interest Change
- -13.6%
- -0.76%
- Short % of Float
- 19.4%
- 9.04%
- Short % of Shares Outstanding
- 18.3%
- 6.30%
- Days to Cover
- 7.82
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $24.68
- –
- 52-Week Low
- $14.68
- –
- 20-Day Moving Average
- $18.00
- –
- 50-Day Moving Average
- $18.73
- –
- 200-Day Moving Average
- $18.54
- –
- Average True Range (14)
- $0.97
- –
- Price Change (1 Week)
- -8.88%
- 1.51%
- Price Change (1 Month)
- -4.87%
- -2.35%
- Price Change (3 Months)
- -11.5%
- -21.1%
- Price Change (6 Months)
- -14.3%
- -22.6%
- Price Change (YTD)
- -25.6%
- -22.6%
- Price Change (1 Year)
- -11.0%
- -20.7%
- Price Change (3 Years)
- -79.9%
- -27.4%
- Price Change (5 Years)
- -81.2%
- -77.3%
- Price Change (10 Years)
- -59.5%
- -62.7%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.77
- 0.79
- Relative Strength Index (14)
- 36.8
- 44.7
- Volatility (1 Year)
- 70.6%
- 80.4%
- Beta (5 Years)
- 0.98
- 1.07
MarginsIndustry
- Pretax Margin
- -4.70%
- -11.8%
- EBITDA Margin
- -0.86%
- -27.7%
- FCF Margin
- 9.02%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- -7.58%
- -51.2%
- Return on Assets (ROA)
- -3.44%
- -40.6%
- Return on Invested Capital (ROIC)
- -5.31%
- -32.9%
- Return on Capital Employed (ROCE)
- -1.95%
- -38.0%
Financial positionIndustry
- Current Ratio
- 3.46
- 3.30
- Quick Ratio
- 1.90
- 2.42
- Debt / Equity
- 0.10
- 0.49
- Debt / FCF
- 0.90
- 4.68
GrowthIndustry
- Revenue Growth (YoY)
- -18.9%
- 7.01%
- Revenue Growth (3Y CAGR)
- 33.1%
- 2.25%
- Revenue Growth (5Y CAGR)
- 32.4%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.59
- 0.40
- Revenue Per Employee
- $2.34M
- $429.29K
- Profits Per Employee
- -$137.27K
- -$683.67K
- Employee Count
- 835
- 75
- WACC
- 9.51%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$92.02M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $720.81M
- $17.46M
- Net Cash Per Share
- $6.82
- $0.72
- Equity (Book Value)
- $1.53B
- $53.27M
- Book Value Per Share
- $14.47
- $1.50
- Tangible Book Value
- $1.50B
- $26.82M
- Working Capital
- $1.62B
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.16M
- -$944.00K
- FCF Per Share
- $1.67
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -6.78%
- -20.8%
- FCF Yield
- 10.4%
- -9.58%
Taxes and interestIndustry
- Interest Expense
- -$78.94M
- $2.93M
- Income Tax
- $22.60M
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.23
- 0.30
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SRPT | S&P 500 | Difference | SRPT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.2% | -2.7% | −5.5 pts | ||
| 3 months | -12.9% | -1.7% | −11.1 pts | ||
| Year to date | -25.6% | +11.9% | −37.5 pts | ||
| 1 year | -11.1% | +12.0% | −23.0 pts | ||
| 3 years | -79.8% | +78.2% | −158.0 pts | -41.4% | +21.2% |
| 5 years | -81.2% | +73.2% | −154.4 pts | -28.4% | +11.6% |
| 10 years | -59.5% | +309.6% | −369.1 pts | -8.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
19M SRPT shares were sold short on Oct 30, 2026, down 13.6% from the previous report, or 19.41% of the shares available to trade. At recent volumes it would take 7.8 days to buy them back. Over the last 20 sessions, 47.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 19,297,522 | -13.6% | 2,467,051 | 7.8 |
| Oct 15, 2026 | 22,330,342 | -2.0% | 2,991,391 | 7.5 |
| Sep 30, 2026 | 22,784,187 | -10.4% | 2,644,045 | 8.6 |
| Sep 15, 2026 | 25,434,681 | +3.3% | 3,170,287 | 8.0 |
| Aug 31, 2026 | 24,621,090 | -9.0% | 2,909,424 | 8.5 |
| Aug 14, 2026 | 27,049,885 | -1.9% | 2,983,896 | 9.1 |
| Jul 31, 2026 | 27,566,969 | -3.2% | 3,142,381 | 8.8 |
| Jul 15, 2026 | 28,489,470 | -0.9% | 3,089,173 | 9.2 |
| Jun 30, 2026 | 28,734,169 | +14.2% | 4,997,302 | 5.8 |
| Jun 15, 2026 | 25,167,342 | +0.2% | 2,767,049 | 9.1 |
| May 29, 2026 | 25,129,233 | +0.4% | 2,661,920 | 9.4 |
| May 15, 2026 | 25,018,640 | +0.4% | 3,417,876 | 7.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?